Offer - Urjas Oil for just ₹ 1
Sevbait DT 400 Tablet is a prescription medicine that is available as a Tablet. Increased Phosphate Levels in the Blood are some of its major therapeutic uses. Secondary and off-label uses of Sevbait DT 400 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Sevbait DT 400 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Sevbait DT 400 Tablet can also lead to other problems, which have been listed below. Such side effects of Sevbait DT 400 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Sevbait DT 400 Tablet's effect is Unknown during pregnancy and Safe for lactating mothers. In addition, Sevbait DT 400 Tablet's effects on the liver, heart and kidney are discussed below in the Sevbait DT 400 Tablet related warnings section.
Sevbait DT 400 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Sevbait DT 400 Tablet in conditions like Intestinal Obstruction. Some other conditions that can be affected by Sevbait DT 400 Tablet are listed in the contraindications section below.
Drug interactions for Sevbait DT 400 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Sevbait DT 400 Tablet is safe while driving, and is addiction.
Sevbait DT 400 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
Is the use of Sevbait DT 400 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Sevbait in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Sevbait DT 400 Tablet safe during breastfeeding?
Sevbait is completely safe for breastfeeding women.
What is the effect of Sevbait DT 400 Tablet on the Kidneys?
Very few cases of side effects of Sevbait on kidney have been reported.
What is the effect of Sevbait DT 400 Tablet on the Liver?
So far, no research has been carried out on the effects of Sevbait on the liver. So it is not known whether taking Sevbait will affect the liver or not.
What is the effect of Sevbait DT 400 Tablet on the Heart?
There is no research available on the side effects of Sevbait on the heart. Therefore, its impact is unknown.
If you are suffering from any of the following diseases, you should not take Sevbait DT 400 Tablet unless your doctor advises you to do so -
Is this Sevbait DT 400 Tablet habit forming or addictive?
Forming a habit of Sevbait DT 400 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Sevbait DT 400 Tablet as it does not make you drowsy.
Is it safe?
Sevbait DT 400 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sevbait DT 400 Tablet for mental disorders.
Interaction between Food and Sevbait DT 400 Tablet
Due to the absence of research, it is difficult to say how Sevbait DT 400 Tablet and food will interact.
Interaction between Alcohol and Sevbait DT 400 Tablet
Information about the interaction of Sevbait DT 400 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135
